Nonetheless, “these findings are congruent with those from the PROTECTED TAVR trial and suggest that reduction in disabling stroke from EPD use is real,” Neel Butala said. He added, however, that “the effect size may be relatively small in all-comer patients.” The results were published simultaneously online in Circulation: Cardiovascular Interventions.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045